Associate Professor, Department of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University, Kochi, Japan.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Apr;113(4):464-71. doi: 10.1016/j.tripleo.2011.04.006. Epub 2011 Jul 20.
The objective of this study was to analyze the relationship between the uptake of (18)F-2-fluoro-2-deoxy-d-glucose (FDG) by positron emission tomography-computerized tomography (PET-CT) and glucose metabolism/hypoxia markers in oral squamous cell carcinoma (OSCC).
Thirty-six patients with OSCC (tongue [n = 23], buccal mucosa [n = 7], and floor of the mouth [n = 6]) were assessed and underwent incisional biopsy and subsequently received FDG-PET-CT. Expressions of hypoxia-inducible factor 1α (HIF-1α), glucose transporter protein 1 (GLUT-1), hexokinase-II (HK-II), and glucose-6-phosphatase (G6Pase) were immunohistochemically quantified, and FDG uptake was evaluated by the maximum standardized uptake values (SUV(max)) at the primary tumor site.
FDG uptake was found to be significantly correlated with the T classification of OSCC but not with other clinicopathologic characteristics, such as the N classification, clinical type, and histologic grade of malignancy. In the early-stage (T1 and T2) tumor, FDG uptake was significantly associated with the expression levels of GLUT-1, HK II, and HIF-1α, and the expression levels of GLUT-1 and HK-II significantly correlated with HIF-1α expression levels. However, there were no correlations between the expression levels of these molecules and SUV(max) in the late-stage (T3 and T4) tumor.
FDG uptake was significantly associated with the expression levels of glucose metabolism-related molecules, such as GLUT-1, HK II, and HIF-1α, especially in early-stage tumors.
本研究旨在分析正电子发射断层扫描-计算机断层扫描(PET-CT)中(18)F-2-氟-2-脱氧-d-葡萄糖(FDG)摄取与口腔鳞状细胞癌(OSCC)中的葡萄糖代谢/缺氧标志物之间的关系。
对 36 例 OSCC 患者(舌 [n=23]、颊黏膜 [n=7]和口底 [n=6])进行评估,并进行切开活检,随后接受 FDG-PET-CT。通过免疫组织化学定量检测缺氧诱导因子 1α(HIF-1α)、葡萄糖转运蛋白 1(GLUT-1)、己糖激酶-II(HK-II)和葡萄糖-6-磷酸酶(G6Pase)的表达,通过原发性肿瘤部位的最大标准化摄取值(SUV(max))评估 FDG 摄取。
FDG 摄取与 OSCC 的 T 分类显著相关,但与其他临床病理特征(如 N 分类、临床类型和组织学恶性程度)无关。在早期(T1 和 T2)肿瘤中,FDG 摄取与 GLUT-1、HK II 和 HIF-1α的表达水平显著相关,GLUT-1 和 HK-II 的表达水平与 HIF-1α的表达水平显著相关。然而,在晚期(T3 和 T4)肿瘤中,这些分子的表达水平与 SUV(max)之间没有相关性。
FDG 摄取与葡萄糖代谢相关分子(如 GLUT-1、HK II 和 HIF-1α)的表达水平显著相关,尤其是在早期肿瘤中。